Lao People's Democratic Republic vs Pakistan: Percentage of bloodstream infection due to methicillin-resistant
Lao People's Democratic Republic
55.9%
in 2022
Pakistan
67.1%
in 2022
Lao People's Democratic Republic rank
6th
Pakistan rank
3rd
Percentage of bloodstream infection due to methicillin-resistant over time
- Lao People's Democratic Republic
- Pakistan
How they compare
Pakistan currently reports 67.1% against 55.9% in Lao People's Democratic Republic, a difference of 11.2%.
That makes Pakistan's figure about 1.2 times Lao People's Democratic Republic's.
Across all 6 years both countries report, Pakistan has been ahead every year.
Lao People's Democratic Republic ranks 6th and Pakistan ranks 3rd of 50 countries.
Pakistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lao People's Democratic Republic | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 9.0% | 52.1% | 43.1% | Pakistan |
| 2020s | 45.3% | 73.0% | 27.8% | Pakistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Lao People's Democratic Republic or Pakistan?
- Pakistan, at 67.1% against 55.9% in Lao People's Democratic Republic as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Lao People's Democratic Republic and Pakistan?
- 11.2%, with Pakistan ahead.
- How many years of comparable data are there for Lao People's Democratic Republic and Pakistan?
- 6 years are reported by both, from 2017 to 2022.
- How do Lao People's Democratic Republic and Pakistan rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Lao People's Democratic Republic ranks 6th and Pakistan ranks 3rd of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.